Bausch Health Companies (BHC) PT Lowered to $25 at BMO Capital
Tweet Send to a Friend
BMO Capital analyst Gary Nachman lowered the price target on Bausch Health Companies (NYSE: BHC) to $25.00 (from $26.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
